Takeda reported 107.16B in Interest Expense on Debt for its fiscal quarter ending in June of 2025.


Interest Expense On Debt Change Date
Astellas Pharma 3.91B 320M Mar/2025
Chugai Pharma 633M 938M Jun/2025
Daiichi Sankyo 1.42B 5.66B Jun/2025
Eisai 916M 174M Jun/2025
Kyowa Hakko Kirin 2.54B 2.4B Jun/2025
M3 638M 451M Jun/2025
Otsuka Holdings 9.73B 4.01B Jun/2025
Shionogi 2.33B 338M Jun/2025
Sumitomo Dainippon 15.6B 28.94B Mar/2025
Takeda 107.16B 56.83B Jun/2025
Terumo 1.28B 1.14B Jun/2025